Atgam - 0009-7224-02 - (EQUINE THYMOCYTE IMMUNE GLOBULIN)

Alphabetical Index


Drug Information of Atgam

Product NDC: 0009-7224
Proprietary Name: Atgam
Non Proprietary Name: EQUINE THYMOCYTE IMMUNE GLOBULIN
Active Ingredient(s): 50    mg/mL & nbsp;   EQUINE THYMOCYTE IMMUNE GLOBULIN
Administration Route(s): INTRAVENOUS
Dosage Form(s): INJECTION, SOLUTION
Coding System: National Drug Codes(NDC)

Labeler Information of Atgam

Product NDC: 0009-7224
Labeler Name: Pharmacia and Upjohn Company
Product Type: HUMAN PRESCRIPTION DRUG
FDA Application Number: BLA103676
Marketing Category: BLA
Start Marketing Date: 19811117

Package Information of Atgam

Package NDC: 0009-7224-02
Package Description: 5 AMPULE in 1 CARTON (0009-7224-02) > 5 mL in 1 AMPULE

NDC Information of Atgam

NDC Code 0009-7224-02
Proprietary Name Atgam
Package Description 5 AMPULE in 1 CARTON (0009-7224-02) > 5 mL in 1 AMPULE
Product NDC 0009-7224
Product Type Name HUMAN PRESCRIPTION DRUG
Non Proprietary Name EQUINE THYMOCYTE IMMUNE GLOBULIN
Dosage Form Name INJECTION, SOLUTION
Route Name INTRAVENOUS
Start Marketing Date 19811117
Marketing Category Name BLA
Labeler Name Pharmacia and Upjohn Company
Substance Name EQUINE THYMOCYTE IMMUNE GLOBULIN
Strength Number 50
Strength Unit mg/mL
Pharmaceutical Classes Immunoglobulin G [EPC],Lymphocyte Function Alteration [PE],Increased T Lymphocyte Destruction [PE],Antibody-Surface Protein Interactions [MoA],Immunoglobulins [Chemical/Ingredient]

Complete Information of Atgam


General Information